Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Diabetes Care Publish Ahead of Print published online ahead of print February 11, 2008
DOI: 10.2337/dc07-1912
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1912v1
31/5/882    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Pérez-Jáuregui, J.
Right arrow Articles by Aguilar-Salinas, C. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Jáuregui, J.
Right arrow Articles by Aguilar-Salinas, C. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

The inclusion of educational messages in laboratory reports aids to complete the diagnostic workup of hyperglycemia.

José Pérez-Jáuregui, MD1, Ana María González-Cardel, BS2, Gabriela Olay-Fuentes, BS3, Alfredo Reza-Albarrán, MD4, Roopa Mehta, MD4 and Carlos A. Aguilar-Salinas, MD4

Dirección Corporativa de Medicina de Laboratorio, Laboratorio Médico del Chopo1;
Especialización en Bioquímica Clínica, Facultad de Química de la Universidad Nacional Autónoma de México2;
Departamento de Inmuno-Química, Carpermor, Laboratorio de Referencia Internacional3;
Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán4. Ciudad de México, México

ABSTRACT

Objective: to evaluate whether educational messages regarding the OGTT indications in the laboratory reports increases the number of OGTT appropriately requested.

Methods: this message was printed on the lab reports of individuals with a FPG between 5.5-6.9 mmol/L: "A FPG between 5.5 and 6.9 mmol/L is considered abnormal by the American Diabetes Association (impaired fasting glucose). An OGTT is recommended if the patient does not have a diagnosis of diabetes and suffers from conditions associated with an increased risk for having type 2 diabetes (i.e. overweight, high blood pressure, abnormal plasma lipids or family history of diabetes)". The number of educational messages printed was 81,099. Results: the intervention resulted in a significant increase in the number of OGTT requested. The OGTT number increased from 78±19 tests per month to 268±48 per month. The intervention resulted in a greater proportion of cases that had an abnormal OGTT.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.